|
|
| | 3-Acetoxy-8(17),13E-labdadien-15-oic acid Basic information |
| Product Name: | 3-Acetoxy-8(17),13E-labdadien-15-oic acid | | Synonyms: | 3-Acetoxy-8(17),13E-labdadien-15-oic acid;2-Pentenoic acid, 5-[6-(acetyloxy)decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]-3-methyl-, [1S-(1α,4aβ,6α,8aα)]- (9CI);13E-labdadien-15-oic acid;3-Acetoxy-8(17) | | CAS: | 63399-37-1 | | MF: | C22H34O4 | | MW: | 362.51 | | EINECS: | | | Product Categories: | | | Mol File: | 63399-37-1.mol |  |
| | 3-Acetoxy-8(17),13E-labdadien-15-oic acid Chemical Properties |
| Boiling point | 465.4±45.0 °C(Predicted) | | density | 1.06±0.1 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 5.16±0.33(Predicted) |
| | 3-Acetoxy-8(17),13E-labdadien-15-oic acid Usage And Synthesis |
| Description | ent-3-Acetoxy-labda-8(17),13-dien-15-oic acid have vasorelaxant and hypotensive actions, the mechanisms underlying the cardiovascular actions of the labdane involve the activation of the endothelial NO-cGMP pathway, the opening of K+ channels and the alteration on Ca2+ mobilization. | | target | Calcium Channel | cAMP | Potassium Channel | NO |
| | 3-Acetoxy-8(17),13E-labdadien-15-oic acid Preparation Products And Raw materials |
|